Epoxide hydrolases: biochemistry and molecular biology.

[1]  J. Meijer,et al.  Identification and Functional Characterization of Human Soluble Epoxide Hydrolase Genetic Polymorphisms* , 2000, The Journal of Biological Chemistry.

[2]  C-Y Chen,et al.  Association of CYP1A1 and microsomal epoxide hydrolase polymorphisms with lung squamous cell carcinoma , 2000, British Journal of Cancer.

[3]  F. Oesch,et al.  Structure of Aspergillus niger epoxide hydrolase at 1.8 A resolution: implications for the structure and function of the mammalian microsomal class of epoxide hydrolases. , 2000, Structure.

[4]  R. Busse,et al.  EDHF: a cytochrome P450 metabolite in coronary arteries. , 2000, Seminars in perinatology.

[5]  J. Haeggström,et al.  Structure, function, and regulation of leukotriene A4 hydrolase. , 2000, American journal of respiratory and critical care medicine.

[6]  J. Haeggström,et al.  Leukotriene A4 hydrolase: a critical role of glutamic acid-296 for the binding of bestatin. , 2000, The Biochemical journal.

[7]  F. Oesch,et al.  Cloning and molecular characterization of a soluble epoxide hydrolase from Aspergillus niger that is related to mammalian microsomal epoxide hydrolase. , 1999, The Biochemical journal.

[8]  B. Hammock,et al.  Inhibition of soluble and microsomal epoxide hydrolase by zinc and other metals. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[9]  A. A. Spector,et al.  Epoxide hydrolases regulate epoxyeicosatrienoic acid incorporation into coronary endothelial phospholipids. , 1999, American journal of physiology. Heart and circulatory physiology.

[10]  R. Busse,et al.  Cytochrome P450 2C is an EDHF synthase in coronary arteries , 1999, Nature.

[11]  D. Christianson,et al.  Detoxification of environmental mutagens and carcinogens: structure, mechanism, and evolution of liver epoxide hydrolase. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[12]  F. Gonzalez,et al.  Targeted Disruption of the Microsomal Epoxide Hydrolase Gene , 1999, The Journal of Biological Chemistry.

[13]  B D Hammock,et al.  Potent urea and carbamate inhibitors of soluble epoxide hydrolases. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[14]  F. Guengerich,et al.  Kinetics of hydrolysis and reaction of aflatoxin B1 exo-8,9-epoxide and relevance to toxicity and detoxication. , 1999, Drug metabolism reviews.

[15]  M. Lieberman,et al.  Mouse leukotriene A4 hydrolase is expressed at high levels in intestinal crypt cells and splenic lymphocytes. , 1999, Gene.

[16]  S. Nigam,et al.  Hepoxilin signaling in intact human neutrophils: biphasic elevation of intracellular calcium by unesterified hepoxilin A3 , 1999, FEBS letters.

[17]  M. Miller,et al.  Symposium overview: the role of genetic polymorphism and repair deficiencies in environmental disease. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[18]  C. Smith,et al.  Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer , 1999, British Journal of Cancer.

[19]  P. Dayer,et al.  Association between lung cancer and microsomal epoxide hydrolase genotypes. , 1998, Cancer research.

[20]  S. G. Kim,et al.  Differential induction of rat hepatic microsomal epoxide hydrolase and rGSTA2 by diazines: the role of cytochrome P450 2E1-mediated metabolic activation. , 1998, Chemico-biological interactions.

[21]  H. Yamazaki,et al.  Activation and detoxication of aflatoxin B1. , 1998, Mutation research.

[22]  E. Jendraschak,et al.  Isolation of human promoter regions by Alu repeat consensus-based polymerase chain reaction. , 1998, Genomics.

[23]  J. S. Sidhu,et al.  Effects of chemical inducers on human microsomal epoxide hydrolase in primary hepatocyte cultures. , 1998, Biochemical pharmacology.

[24]  C. J. Omiecinski,et al.  Post-transcriptional regulation of human microsomal epoxide hydrolase. , 1998, Pharmacogenetics.

[25]  C. Hassett,et al.  Human microsomal epoxide hydrolase: 5'-flanking region genetic polymorphisms. , 1998, Carcinogenesis.

[26]  R. Armstrong,et al.  Mechanism of microsomal epoxide hydrolase. Semifunctional site-specific mutants affecting the alkylation half-reaction. , 1998, Biochemistry.

[27]  G. Carlson.  Metabolism of styrene oxide to styrene glycol by mouse liver and lung. , 1998, Journal of toxicology and environmental health. Part A.

[28]  H. Liu,et al.  Regulation of Leukotriene A4 Hydrolase Activity in Endothelial Cells by Phosphorylation* , 1997, The Journal of Biological Chemistry.

[29]  S. Rappaport,et al.  Measurement of benzene oxide in the blood of rats following administration of benzene. , 1997, Carcinogenesis.

[30]  A. Elfarra,et al.  Epoxide hydrolase-dependent metabolism of butadiene monoxide to 3-butene-1,2-diol in mouse, rat, and human liver. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[31]  B. Hammock,et al.  Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase , 1997, Nature Medicine.

[32]  W. Hinz,et al.  Visualization of a covalent intermediate between microsomal epoxide hydrolase, but not cholesterol epoxide hydrolase, and their substrates. , 1997, European journal of biochemistry.

[33]  C. J. Omiecinski,et al.  Human hepatic microsomal epoxide hydrolase: comparative analysis of polymorphic expression. , 1997, Archives of Biochemistry and Biophysics.

[34]  A. Elfarra,et al.  Oxidation of butadiene monoxide to meso- and (+/-)-diepoxybutane by cDNA-expressed human cytochrome P450s and by mouse, rat, and human liver microsomes: evidence for preferential hydration of meso-diepoxybutane in rat and human liver microsomes. , 1997, Archives of biochemistry and biophysics.

[35]  F. Gonzalez,et al.  Stereoselective epoxidation and hydration at the K-region of polycyclic aromatic hydrocarbons by cDNA-expressed cytochromes P450 1A1, 1A2, and epoxide hydrolase. , 1996, Biochemistry.

[36]  M. Pirmohamed,et al.  Interindividual and interspecies variation in hepatic microsomal epoxide hydrolase activity: studies with cis-stilbene oxide, carbamazepine 10, 11-epoxide and naphthalene. , 1996, The Journal of pharmacology and experimental therapeutics.

[37]  G. Carlson,et al.  Pneumotoxicity and hepatotoxicity of styrene and styrene oxide. , 1996, Journal of toxicology and environmental health.

[38]  J. Meijer,et al.  Structural characterization of the human soluble epoxide hydrolase gene (EPHX2). , 1996, Biochemical and biophysical research communications.

[39]  C. von Schacky,et al.  The human leukotriene A4 hydrolase gene is expressed in two alternatively spliced mRNA forms. , 1996, The Biochemical journal.

[40]  F. Oesch,et al.  Asp, Asp, and His Form the Catalytic Triad of Rat Soluble Epoxide Hydrolase (*) , 1996, The Journal of Biological Chemistry.

[41]  A. Gaedigk,et al.  Epitope mapping studies with human anti-cytochrome P450 3A antibodies. , 1996, Molecular pharmacology.

[42]  L. Holmes,et al.  Phenytoin embryopathy: effect of epoxide hydrolase inhibitor on phenytoin exposure in utero in C57BL/6J mice. , 1995, Biochemical and molecular medicine.

[43]  J. Muglia,et al.  Anticonvulsant hypersensitivity syndrome. , 1995, Archives of internal medicine.

[44]  B. Borhan,et al.  Mechanism of Soluble Epoxide Hydrolase , 1995, The Journal of Biological Chemistry.

[45]  M. Pirmohamed,et al.  Genetic analysis of microsomal epoxide hydrolase in patients with carbamazepine hypersensitivity. , 1995, Biochemical pharmacology.

[46]  B. Borhan,et al.  Improved radiolabeled substrates for soluble epoxide hydrolase. , 1995, Analytical biochemistry.

[47]  J. Haeggström,et al.  Evidence for a catalytic role of tyrosine 383 in the peptidase reaction of leukotriene A4 hydrolase. , 1995, European journal of biochemistry.

[48]  J. Evans,et al.  Cloning and characterization of the human leukotriene A4 hydrolase gene. , 1995, European journal of biochemistry.

[49]  B. Borhan,et al.  Molecular and Biochemical Evidence for the Involvement of the Asp-333–His-523 Pair in the Catalytic Mechanism of Soluble Epoxide Hydrolase (*) , 1995, The Journal of Biological Chemistry.

[50]  C. Pace-Asciak.  Hepoxilins: a review on their cellular actions. , 1994, Biochimica et biophysica acta.

[51]  D. Reynaud,et al.  Hepoxilin A3 formation in the rat pineal gland selectively utilizes (12S)-hydroperoxyeicosatetraenoic acid (HPETE), but not (12R)-HPETE. , 1994, The Journal of biological chemistry.

[52]  C. Hassett,et al.  The human microsomal epoxide hydrolase gene (EPHX1): complete nucleotide sequence and structural characterization. , 1994, Genomics.

[53]  B. Hammock,et al.  Cloning and expression of soluble epoxide hydrolase from potato. , 1994, The Plant journal : for cell and molecular biology.

[54]  J. A. Bond,et al.  Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation. , 1994, Carcinogenesis.

[55]  H. Jörnvall,et al.  Purification and initial characterization of microsomal epoxide hydrolase from the human adrenal gland. , 1994, Biochimica et biophysica acta.

[56]  J. Haeggström,et al.  Zinc and other divalent cations inhibit purified leukotriene A4 hydrolase and leukotriene B4 biosynthesis in human polymorphonuclear leukocytes. , 1994, Archives of biochemistry and biophysics.

[57]  D. Grant,et al.  Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactions. , 1994, Pharmacogenetics.

[58]  R. Armstrong,et al.  Microsomal and soluble epoxide hydrolases are members of the same family of C-X bond hydrolase enzymes. , 1994, Chemical research in toxicology.

[59]  J. S. Sidhu,et al.  Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. , 1994, Human molecular genetics.

[60]  F. Oesch,et al.  Sequence similarity of mammalian epoxide hydrolases to the bacterial haloalkane dehalogenase and other related proteins , 1994, FEBS letters.

[61]  F. Oesch,et al.  Benzene metabolism by reconstituted cytochromes P450 2B1 and 2E1 and its modulation by cytochrome b5, microsomal epoxide hydrolase, and glutathione transferases: evidence for an important role of microsomal epoxide hydrolase in the formation of hydroquinone. , 1993, Toxicology and applied pharmacology.

[62]  B. Hammock,et al.  Molecular cloning and expression of murine liver soluble epoxide hydrolase. , 1993, The Journal of biological chemistry.

[63]  B. Hammock,et al.  cDNA cloning and expression of a soluble epoxide hydrolase from human liver. , 1993, Archives of biochemistry and biophysics.

[64]  F. Oesch,et al.  Isolation and characterization of a cDNA encoding rat liver cytosolic epoxide hydrolase and its functional expression in Escherichia coli. , 1993, The Journal of biological chemistry.

[65]  C. Kasper,et al.  Expression of rat microsomal epoxide hydrolase in Escherichia coli. Identification of a histidyl residue essential for catalysis. , 1993, The Journal of biological chemistry.

[66]  R. Holubkov,et al.  Human peripheral lymphocytes as indicators of microsomal epoxide hydrolase activity in liver and lung. , 1993, Pharmacogenetics.

[67]  D. Reynaud,et al.  Hepoxilin A3 is the endogenous lipid mediator opposing hypotonic swelling of intact human platelets. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[68]  D. Zeldin,et al.  Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase. , 1993, The Journal of biological chemistry.

[69]  J. Haeggström,et al.  Leukotriene A4 hydrolase: structural and functional properties of the active center. , 1993, Journal of lipid mediators.

[70]  E. Dietze,et al.  Inhibition of epoxide hydrolase from human, monkey, bovine, rabbit and murine liver by trans-3-phenylglycidols. , 1993, Comparative biochemistry and physiology. B, Comparative biochemistry.

[71]  Chi‐Huey Wong,et al.  Development of selective tight-binding inhibitors of leukotriene A4 hydrolase. , 1993, Journal of medicinal chemistry.

[72]  J. Leeder,et al.  Human anti-cytochrome P450 antibodies in aromatic anticonvulsant-induced hypersensitivity reactions. , 1992, The Journal of pharmacology and experimental therapeutics.

[73]  B. Borhan,et al.  Characterization of the cytosolic epoxide hydrolase-catalyzed hydration products from 9,10:12,13-diepoxy stearic esters. , 1992, Archives of biochemistry and biophysics.

[74]  F. Oesch,et al.  An impaired peroxisomal targeting sequence leading to an unusual bicompartmental distribution of cytosolic epoxide hydrolase , 1991, FEBS letters.

[75]  D. V. Van Dyke,et al.  Differences in Phenytoin Biotransformation and Susceptibility to Congenital Malformations: A Review , 1991, DICP : the annals of pharmacotherapy.

[76]  A. Hinnen,et al.  Heterologous expression of human microsomal epoxide hydrolase in Saccharomyces cerevisiae. Study of the valpromide-carbamazepine epoxide interaction. , 1991, Biochemical pharmacology.

[77]  E. Dietze,et al.  Inhibition of cytosolic epoxide hydrolase by trans-3-phenylglycidols. , 1991, Biochemical pharmacology.

[78]  E. Corey,et al.  Hepoxilin A3 (HxA3) is formed by the rat aorta and is metabolized into HxA3-C, a glutathione conjugate. , 1991, Biochimica et biophysica acta.

[79]  K. Andersson,et al.  Studies on the intracellular distributions of soluble epoxide hydrolase and of catalase by digitonin-permeabilization of hepatocytes isolated from control and clofibrate-treated mice. , 1991, European journal of biochemistry.

[80]  F. Oesch,et al.  Rat and human liver cytosolic epoxide hydrolases: evidence for multiple forms at level of protein and mRNA. , 1990, Environmental health perspectives.

[81]  C. Falany,et al.  Glucocorticoid repression and basal regulation of the epoxide hydrolase promoter. , 1990, Archives of biochemistry and biophysics.

[82]  F. Beland,et al.  Mutagenicity of oxidized microsomal metabolites of 1-nitropyrene in Chinese hamster ovary cells. , 1990, Mutagenesis.

[83]  O. Rådmark,et al.  Leukotriene A4 hydrolase: analysis of some human tissues by radioimmunoassay. , 1989, Biochimica et biophysica acta.

[84]  C. J. Omiecinski,et al.  Xenobiotic microsomal epoxide hydrolase: 5' sequence of the human gene. , 1989, Biochimica et biophysica acta.

[85]  J. Depierre,et al.  Proliferation of peroxisomes and induction of cytosolic and microsomal epoxide hydrolases in different strains of mice and rats after dietary treatment with clofibrate. , 1989, Xenobiotica; the fate of foreign compounds in biological systems.

[86]  W. S. Lee,et al.  Purification of hepoxilin epoxide hydrolase from rat liver. , 1989, The Journal of biological chemistry.

[87]  C. Hassett,et al.  Rabbit microsomal epoxide hydrolase: isolation and characterization of the xenobiotic metabolizing enzyme cDNA. , 1989, Archives of biochemistry and biophysics.

[88]  T. Fujita,et al.  Induction of rat liver microsomal cytochrome P-450 isozymes and epoxide hydrolase by a series of 4'-substituted-2,3,4,5-tetrachlorobiphenyls. , 1988, Toxicology.

[89]  S. Spielberg,et al.  Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. , 1988, The Journal of clinical investigation.

[90]  N. Kitteringham,et al.  An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin. , 1988, British journal of clinical pharmacology.

[91]  F. Oesch,et al.  Human liver cytosolic epoxide hydrolases. , 1988, European journal of biochemistry.

[92]  F. Oesch,et al.  Purification and characterization of rat-liver cytosolic epoxide hydrolase. , 1988, European journal of biochemistry.

[93]  B. Hammock,et al.  Increased cholesterol epoxide hydrolase activity in clofibrate-fed animals. , 1988, Biochemical pharmacology.

[94]  D. Phillips,et al.  Further metabolism of diol-epoxides of chrysene and dibenz[a,c]anthracene to DNA binding species as evidenced by 32P-postlabelling analysis. , 1988, Carcinogenesis.

[95]  O. Mcbride,et al.  Human microsomal xenobiotic epoxide hydrolase. Complementary DNA sequence, complementary DNA-directed expression in COS-1 cells, and chromosomal localization. , 1988, The Journal of biological chemistry.

[96]  M. Jackson,et al.  Induction of microsomal epoxide hydrolase by nitrosamines in rat liver. Effect on messenger ribonucleic acids. , 1988, Biochemical pharmacology.

[97]  B. Hammock,et al.  Purification of microsomal epoxide hydrolase from liver of rhesus monkey: partial separation of cis- and trans-stilbene oxide hydrolase. , 1987, Archives of biochemistry and biophysics.

[98]  S. K. Yang,et al.  Stereoselective formations of K-region and non-K-region epoxides in the metabolism of chrysene by rat liver microsomal cytochrome P-450 isozymes. , 1987, Molecular pharmacology.

[99]  G. Bellucci,et al.  The metabolism of carbamazepine in humans: steric course of the enzymatic hydrolysis of the 10,11-epoxide. , 1987, Journal of medicinal chemistry.

[100]  B. Hammock,et al.  Inhibition of epoxide hydrolases and glutathione S-transferases by 2-, 3-, and 4-substituted derivatives of 4'-phenylchalcone and its oxide. , 1987, Archives of biochemistry and biophysics.

[101]  J. Depierre,et al.  Induction of cytosolic and microsomal epoxide hydrolases and proliferation of peroxisomes and mitochondria in mouse liver after dietary exposure to p-chlorophenoxyacetic acid, 2,4-dichlorophenoxyacetic acid and 2,4,5-trichlorophenoxyacetic acid. , 1987, Biochemical pharmacology.

[102]  S. Månér,et al.  Induction of liver microsomal epoxide hydrolase, UDP-glucuronyl transferase and cytosolic glutathione transferase in different rodent species by 2-acetylaminofluorene or 3-methylcholanthrene. , 1987, Xenobiotica; the fate of foreign compounds in biological systems.

[103]  F. Oesch,et al.  Distribution and inducibility of cytosolic epoxide hydrolase in male Sprague-Dawley rats. , 1986, Biochemical pharmacology.

[104]  A. Sevanian,et al.  The cytotoxic and mutagenic properties of cholesterol oxidation products. , 1986, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[105]  J. Depierre,et al.  Subcellular and organ distribution of cholesterol epoxide hydrolase in the rat. , 1986, Biochimica et biophysica acta.

[106]  D. Jerina,et al.  7-Dehydrocholesterol 5,6 beta-oxide as a mechanism-based inhibitor of microsomal cholesterol oxide hydrolase. , 1986, The Journal of biological chemistry.

[107]  A. B. Graham,et al.  Microsomal epoxide hydrolase of rat liver. Purification and characterization of enzyme fractions with different chromatographic characteristics. , 1986, The Biochemical journal.

[108]  A. Sevanian,et al.  Catalytic properties and inhibition of hepatic cholesterol-epoxide hydrolase. , 1986, The Journal of biological chemistry.

[109]  F. Fitzpatrick,et al.  Enzymatic hydration of leukotriene A4. Purification and characterization of a novel epoxide hydrolase from human erythrocytes. , 1985, The Journal of biological chemistry.

[110]  D. Jerina,et al.  Differential stereoselectivity of cytochromes P-450b and P-450c in the formation of naphthalene and anthracene 1,2-oxides. The role of epoxide hydrolase in determining the enantiomer composition of the 1,2-dihydrodiols formed. , 1985, The Journal of biological chemistry.

[111]  D. Jerina,et al.  Properties of liver microsomal cholesterol 5,6-oxide hydrolase. , 1985, Archives of biochemistry and biophysics.

[112]  G. Prestwich,et al.  Cyclopropyl oxiranes: reversible inhibitors of cytosolic and microsomal epoxide hydrolases. , 1985, Archives of biochemistry and biophysics.

[113]  A. Sevanian,et al.  Cholesterol epoxide is a direct-acting mutagen. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[114]  T. Komatsu,et al.  Mouse liver musomal cholesterol epoxide hydrolase: A specific inhibition of its activity by 5,6α-Imino-5α-cholestan-3α-OL☆ , 1983 .

[115]  D. Jerina,et al.  Distinct rat hepatic microsomal epoxide hydrolases catalyze the hydration of cholesterol 5,6 alpha-oxide and certain xenobiotic alkene and arene oxides. , 1983, Archives of biochemistry and biophysics.

[116]  M. Hamberg,et al.  Evidence for a carbocation intermediate in the enzymatic transformation of leukotriene A4 into leukotriene B4. , 1999, Advances in experimental medicine and biology.

[117]  W. Hinz,et al.  Catalytic triad of microsomal epoxide hydrolase: replacement of Glu404 with Asp leads to a strongly increased turnover rate. , 1999, The Biochemical journal.

[118]  F. Oesch,et al.  Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. , 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[119]  F. Oesch,et al.  Recombinant expression of human microsomal epoxide hydrolase protects V79 Chinese hamster cells from styrene oxide‐ but not from ethylene oxide‐induced DNA strand breaks , 1997, Environmental and molecular mutagenesis.

[120]  F. Oesch,et al.  Gene evolution of epoxide hydrolases and recommended nomenclature. , 1995, DNA and cell biology.

[121]  D. Zeldin,et al.  Metabolism of epoxyeicosatrienoic acids by cytosolic epoxide hydrolase: substrate structural determinants of asymmetric catalysis. , 1995, Archives of biochemistry and biophysics.

[122]  G. Bellucci,et al.  Kinetics and stereochemistry of the microsomal epoxide hydrolase-catalyzed hydrolysis of cis-stilbene oxides. , 1994, Chirality.

[123]  J. Haeggström,et al.  Novel structural and functional properties of leukotriene A4 hydrolase. Implications for the development of enzyme inhibitors. , 1994, Advances in prostaglandin, thromboxane, and leukotriene research.

[124]  E. Dietze,et al.  Spectrophotometric substrates for cytosolic epoxide hydrolase. , 1994, Analytical biochemistry.

[125]  H. Glatt,et al.  Genotoxicity characteristics of reverse diol-epoxides of chrysene. , 1993, Carcinogenesis.

[126]  E. Vesell.  Genetic factors that regulate cytosolic epoxide hydrolase activity in normal human lymphocytes. , 1991, Annales de genetique.

[127]  J. Depierre,et al.  Cytosolic epoxide hydrolase. , 1988, Chemico-biological interactions.

[128]  J. Depierre,et al.  Induction of cytosolic and microsomal epoxide hydrolases in mouse liver by peroxisome proliferators, with special emphasis on structural analogues of 2-ethylhexanoic acid. , 1988, Chemico-biological interactions.

[129]  R. Armstrong,et al.  Enzyme-catalyzed detoxication reactions: mechanisms and stereochemistry. , 1987, CRC critical reviews in biochemistry.

[130]  R. Combes,et al.  Activation of benzo[a]pyrene and aflatoxin B1 to mutagenic chemical species by microsomal preparations from rat liver and small intestine in relation to microsomal epoxide hydrolase. , 1986, Mutagenesis.

[131]  F. Oesch,et al.  Rat cytosolic epoxide hydrolase. , 1986, Advances in experimental medicine and biology.

[132]  J. Rydström,et al.  Subcellular distribution, catalytic properties and partial purification of epoxide hydrolase in the human adrenal gland. , 1985, Chemico-biological interactions.

[133]  F. Oesch,et al.  Endogenous role of microsomal epoxide hydrolase. Ontogenesis, induction inhibition, tissue distribution, immunological behaviour and purification of microsomal epoxide hydrolase with 16 alpha, 17 alpha-epoxyandrostene-3-one as substrate. , 1982, European journal of biochemistry.